The University of Alabama at Birmingham’s James Markert, M.D., MPH, James Garber Galbraith Endowed Chair of Neurosurgery and Department of Neurosurgery professor, has been elected to the Board of Directors of the American Board of Neurological Surgery (ABNS).
This prestigious appointment highlights Markert’s significant contributions to the field of neurological surgery and his commitment to advancing the standards of neurosurgical practice.
The Board of Directors of the ABNS consists of 15 directors and officers selected from practicing, board-certified neurosurgeons. Directors are elected after receiving nominations from various neurosurgical organizations. Each director serves a six-year term, with two to three new directors joining the board annually. Criteria for election includes ABNS board certification, active and routine involvement in the practice of neurological surgery, a vested interest in the mission of the ABNS, and a commitment to upholding the profession of neurosurgery so the reputation of the board remains the gold standard in neurosurgery.
“It is a real privilege to serve as part of an organization with the mission of the ABNS” said Markert. “It is not surprising that UAB has had six faculty members serve on the board over the years.”
The ABNS is dedicated to encouraging the study, improving the practice, and elevating the standards of neurological surgery. Its primary purposes include conducting examinations for candidates seeking board certification and issuing certificates to those who meet the board's stringent requirements. Certification by the ABNS involves a thorough review and evaluation of an applicant's education, training, and practice qualifications, along with successful completion of both written and oral examinations.
Markert’s election to the ABNS Board of Directors is a testament to his excellence in the field of neurosurgery. His expertise and leadership will undoubtedly contribute to the ABNS's mission of advancing the science and practice of neurological surgery to better serve patients.